Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
methylphenidate (ritalin) (1 trial)
pimavanserin (nuplazid) (1 trial)
quetiapine (seroquel) (1 trial)
spironolactone (aldactone) (1 trial)
ban2401 (1 trial)
cad106 (1 trial)
cnp520 (1 trial)
doconexent (1 trial)
e2814 (1 trial)
gantenerumab (3 trials)
glucose (1 trial)
malic acid (1 trial)
resveratrol (1 trial)
solanezumab (2 trials)
bosutinib (bosulif) (1 trial)
donepezil (aricept) (1 trial)
enduramide (1 trial)
estrogen (1 trial)
formoterol (foradil) (1 trial)
insulin detemir (Levemir) (1 trial)
insulin human (humulin) (1 trial)
lidocaine (xylocaine) (1 trial)
mk-6240 (1 trial)
mw189 (1 trial)
nicotinamide (1 trial)
pepinemab (1 trial)
prilocaine (citanest) (1 trial)
progesterone (progestasert) (1 trial)
sargramostim (leukine) (1 trial)
sodium chloride (1 trial)
sodium phenylbutyrate (buphenyl) (1 trial)
sucrose (1 trial)
taurursodiol (Relyvrio) (1 trial)
tt301 (1 trial)
valaciclovir (Valtrex) (1 trial)
123i impy (1 trial)
allopregnanolone (1 trial)
av-1451 (1 trial)
contraloid (1 trial)
emtricitabine (emtriva) (1 trial)
npt088 (1 trial)
verdiperstat (1 trial)
xpro1595 (1 trial)
creatine (1 trial)
Alzheimer Disease (Phase 4)
Cognition Disorders (Phase 1)
Cognitive Dysfunction (Phase 4)
Dementia (Phase 4)
Diabetes Mellitus (Phase 4)
Lewy Body Disease (Phase 2)
Trials (31 total)
Trial APIs (44 total)